About Trevi
Trevi Health Ventures is a healthcare investment firm with over $200 million under management. The investment team combines experienced investment professionals and senior-level executives and entrepreneurs with proven track records.
Trevi provides development and growth capital for private healthcare companies with emphasis on medical devices, biopharmaceuticals and healthcare services.
The firm was founded in 2005 and has offices in New York and London. The firm directly invests $5-15 million in each company. The firm also has strategic affiliations that provide flexible sources of capital for larger transactions, including buy-outs, recapitalizations and debt financings.
LATEST NEWS
- February 3, 2010: MedAvante Responds to USA TODAY Story on Antidepressant Effectiveness
- January 28, 2010: Omeros Announces National Institute on Drug Abuse's Support for Phase 2 Clinical Study in Addiction Program
- January 27, 2010: Small Bone Innovations Announces First Surgeries in Malaysia through its Asia Pacific Joint Venture
- January 14, 2010: MedAvante to Deliver Remote, Expert Patient Assessment in $25 Million, Innovative NIMH Study of Early Schizophrenia Treatment